Pesquisas alternativas:
after range » after orange (Expandir a Pesquisa), after strange (Expandir a Pesquisa), after change (Expandir a Pesquisa)
range scale » change scale (Expandir a Pesquisa), large scale (Expandir a Pesquisa), range scanner (Expandir a Pesquisa)
after range » after orange (Expandir a Pesquisa), after strange (Expandir a Pesquisa), after change (Expandir a Pesquisa)
range scale » change scale (Expandir a Pesquisa), large scale (Expandir a Pesquisa), range scanner (Expandir a Pesquisa)
1
“...Objective: This study was conducted to compare the efficacy and safety of addition of two drugs...”
Obter o texto integral
Obter o texto integral
Artigo
2
Por White, M. C., Randall, K., Capo‐Chichi, N. F. E., Sodogas, F., Quenum, S., Wright, K., Close, K. L., Russ, S., Sevdalis, N., Leather, A. J. M.
Publicado no Br J Surg (2019)
“... outcomes, measured using the WHO Behaviourally Anchored Rating Scale (WHOBARS), safety questionnaires...”Publicado no Br J Surg (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“... assessment using the Vancouver scale showed that 6 and 12 months after treatment, the severity of objective...”
Obter o texto integral
Obter o texto integral
Artigo
4
Por Anbari, Anas A.
Publicado em 2013
“...PURPOSE: To report the efficacy, safety, and reliability of autologous cryoprecipitate in pterygium...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Ruiz‐Argüelles, G. J., Olivares‐Gazca, J. C., Olivares‐Gazca, M., Leon‐Peña, A. A., Murrieta‐Alvarez, I., Cantero‐Fortiz, Y., Gomez‐Cruz, G. B., Ruiz‐Argüelles, A., Priesca‐Marin, M., Ruiz‐Delgado, G. J.
Publicado no Clin Exp Immunol (2019)
“... transplantation (HSCT) has been performed in patients with multiple sclerosis (MS). After June 2015, 617 new...”Publicado no Clin Exp Immunol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por A. E. Karateev, E. S. Filatova, E. Yu. Pogozheva, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, V. I. Mazurov, A. Yu. De, A. A. Baranov, N. A. Lapkina, G. V. Lukina, N. A. Kiryukhina, S. Yu. Davidyan, T. S. Salnikova, R. R. Samigullina, D. S. Chakieva, I. M. Marusenko, O. V. Semagina, M. Yu. Semchenkova, A. F. Davydova, E. V. Kalinina
Publicado em 2020-05-01
Assuntos:
“...safety...”Publicado em 2020-05-01
Obter o texto integral
Artigo
7
Por Scharf, C., Ng, G.A., Wieczorek, M., Deneke, T., Furniss, S.S., Murray, St., Debruyne, Ph., Hobson, N., Berntsen, R.F., Schneider, M.A., Hauer, H.A., Halimi, F., Boveda, S., Asbach, S., Boesche, L., Zimmermann, M., Brigadeau, F., Taieb, J., Merkel, M., Pfyffer, M., Brunner-La Rocca, H.P., Boersma, L.V.A.
Publicado em 2012
“... success rate of 82% [median 80%, interquartile range (IQR) 74–90%], a first procedure success rate of 72...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Jackson, Daniel A., Patel, Alden V., Darracott, Robert M., Hanel, Ricardo A., Freeman, William D., Hanley, Daniel F.
Publicado em 2013
“... doses (range 1–17) were given. Worsening EVD catheter tract hemorrhage after rt-PA was 46.7 %, with a...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Hutcheson, Katherine A., Lewin, Jan S., Barringer, Denise A., Lisec, Asher, Gunn, Brandon, Moore, Michael W.S., Holsinger, F. Christopher
Publicado em 2012
“... (PSS-HN), Swallowing Safety Scale (NIH-SSS), and MBSImp. RESULTS: Twenty-nine patients previously...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Hauser, R A, Schapira, A H V, Barone, P, Mizuno, Y, Rascol, O, Busse, M, Debieuvre, C, Fraessdorf, M, Poewe, W, Pramipexole ER Studies Group
Publicado no Eur J Neurol (2014)
“...BACKGROUND AND PURPOSE: To assess the long-term safety and efficacy of pramipexole as a once-daily...”Publicado no Eur J Neurol (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Macmillan, A. K., Mackie, H., Hosking, J. E., Witten, K., Smith, M., Field, A., Woodward, A., Hoskins, R., Stewart, J., van der Werf, B., Baas, P.
Publicado no BMC Public Health (2018)
“... Mua – Future Streets, a mixed-methods, controlled before-after intervention study to assess the effect...”Publicado no BMC Public Health (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por van der Post, J P, de Visser, S J, de Kam, M L, Woelfler, M, Hilt, D C, Vornov, J, Burak, E S, Bortey, E, Slusher, B S, Limsakun, T, Cohen, A F, van Gerven, J M A
Publicado em 2005
“... (EEG), body sway and Visual Analogue Scales (VAS). RESULTS: CNS effects were mainly observed after...”Publicado em 2005
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Heiberger, Amy L., Ngorsuraches, Surachat, Olgun, Gokhan, Luze, Lisa, Leimbach, Caitlin, Madison, Holly, Lakhani, Saquib A.
Publicado no J Pediatr Pharmacol Ther (2018)
“... at an average rate of 1.02 ± 0.50 mg/kg/hr, with a range of 0.07 to 2.0 mg/kg/hr. The duration of ketamine...”Publicado no J Pediatr Pharmacol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Pang, Peter S., Butler, Javed, Collins, Sean P., Cotter, Gad, Davison, Beth A., Ezekowitz, Justin A., Filippatos, Gerasimos, Levy, Phillip D., Metra, Marco, Ponikowski, Piotr, Teerlink, John R., Voors, Adriaan A., Bharucha, David, Goin, Kathleen, Soergel, David G., Felker, G. Michael
Publicado no Eur Heart J (2017)
“...-to-treat. Overall, 621 patients were enrolled. After 254 patients, a pre-specified interim analysis...”Publicado no Eur Heart J (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por S. B. Artemyeva, Yu. O. Papina, O. A. Shidlovskaya, A. V. Monakhova, D. V. Vlodavets
Publicado em 2022-02-01
Assuntos:
“...safety...”Publicado em 2022-02-01
Obter o texto integral
Artigo
16
Por Shovlin, C. L., Millar, C. M., Droege, F., Kjeldsen, A., Manfredi, G., Suppressa, P., Ugolini, S., Coote, N., Fialla, A. D., Geisthoff, U., Lenato, G. M., Mager, H. J., Pagella, F., Post, M. C., Sabbà, C., Sure, U., Torring, P. M., Dupuis-Girod, S., Buscarini, E.
Publicado no Orphanet J Rare Dis (2019)
“... episodes and 7/14 (50%) Rivaroxaban episodes. By a 4 point scale of increasing severity, there was a trend...”Publicado no Orphanet J Rare Dis (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Viscardi, Rose M., Othman, Ahmed A., Hassan, Hazem E., Eddington, Natalie D., Abebe, Elias, Terrin, Michael L., Kaufman, David A., Waites, Ken B.
Publicado em 2013
“... performed a nonrandomized, single-arm open-label study of the pharmacokinetics (PK) and safety...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Canales, Cecilia, Strom, Suzanne, Anderson, Cynthia T., Fortier, Michelle A., Cannesson, Maxime, Rinehart, Joseph B., Kain, Zeev N., Perret, Danielle
Publicado no Br J Anaesth (2019)
Assuntos:
“...Quality and Patient Safety...”Publicado no Br J Anaesth (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Huang, David T., Clermont, Gilles, Kong, Lan, Weissfeld, Lisa A., Sexton, J. Bryan, Rowan, Kathy M., Angus, Derek C.
Publicado em 2010
“... the Safety Attitudes Questionnaire-ICU version, a validated instrument that assesses safety culture across...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Lisa, C., Zaldivar, R., Fernández-Vega Cueto, A., Sanchez-Avila, R. M., Madrid-Costa, D., Alfonso, J. F.
Publicado no J Ophthalmol (2018)
“...). The mean UDVA (logMAR scale) was 1.15 ± 0.67 preoperatively, 0.88 ± 0.69 six months after ICRS implantation...”Publicado no J Ophthalmol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo